BPH - Benign Prostatic Enlargement - Results from #1460

REVIEW UroToday

The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study August 16, 2016

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies August 15, 2016

Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia August 11, 2016

The Endothelium-Dependent Nitric Oxide-cGMP Pathway August 10, 2016

Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors August 10, 2016

Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship? August 9, 2016

Discriminating in Favour of or Against Men with Increased Risk of Finasteride-Related Side-Effects? August 9, 2016

MRI evaluation of benign prostatic hyperplasia: Correlation with international prostate symptom score August 8, 2016

The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review August 5, 2016

Diagnosis and treatment patterns of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia in Murjani General Hospital, Central Kalimantan, Indonesia August 5, 2016

Prostatic Artery Embolization: A Promising Technique in the Treatment of High-Risk Patients with Benign Prostatic Hyperplasia August 5, 2016

Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis August 4, 2016

Holmium Laser Enucleation of the Prostate is Safe for Patients Above 80 Years: A Prospective Study August 4, 2016

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria August 4, 2016

Short- to Midterm Safety and Efficacy of Prostatic Artery Embolization: A Systematic Review August 4, 2016

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations August 2, 2016

Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome August 2, 2016

Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link? August 2, 2016

Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms July 31, 2016

Urolift: a New Face of Minimally Invasive Surgical Technique for Benign Prostatic Hyperplasia? July 28, 2016

Page 74 of 140